Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Eye Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01997489
What this trial is testing

Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.

Who this might be right for
Fabry Disease
Rigshospitalet, Denmark 39
Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT01736592
What this trial is testing

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Who this might be right for
Stargardt's Disease
Sanofi 27
Testing effectiveness (Phase 2)WithdrawnNCT06087731
What this trial is testing

Efficacy and Safety of Tocilizumab for TAO

Who this might be right for
TocilizumabThyroid Associated Ophthalmopathy
Sun Yat-sen University
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableLooking for participantsNCT06881771
What this trial is testing

FECD-TRACE: Fuchs' Endothelial Corneal Dystrophy TRAjectory and Correlation With Genotype in the United Kingdom

Who this might be right for
Fuchs DystrophyFuchs' Endothelial DystrophyFuchs' Endothelial Corneal Dystrophy of Bilateral Eyes+2 more
University College, London 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06625411
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 132
Testing effectiveness (Phase 2)WithdrawnNCT00514982
What this trial is testing

Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome

Who this might be right for
Hermanski-Pudlak SyndromeColitisCytokines+2 more
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableEnded earlyNCT02584413
What this trial is testing

Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma

Who this might be right for
Neurofibromatosis Type 1
Washington University School of Medicine 29
Not applicableLooking for participantsNCT05584488
What this trial is testing

Allergy and Immunology Natural History Study

Who this might be right for
Immune DeficiencyImmune Dysregulation DisorderAllergic Inflammation
Columbia University 10,000
Testing effectiveness (Phase 2)Study completedNCT02077361
What this trial is testing

An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia

Who this might be right for
Choroideremia
University of Alberta 6
Not applicableStudy completedNCT02542644
What this trial is testing

Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT

Who this might be right for
Fuchs' Endothelial Dystrophy
Medical University of Vienna 12
Post-approval studies (Phase 4)Study completedNCT02378298
What this trial is testing

Rituximab (RTX) Therapy in Patients With Active TAO

Who this might be right for
Ophthalmopathy, Thyroid-Associated
Göteborg University 38
Not applicableUnknownNCT03619434
What this trial is testing

Femtolaser Assisted Keratoplasty Versus Conventional Keratoplasty

Who this might be right for
KeratoconusFuchs DystrophyCorneal Disease
University of Southampton 30
Large-scale testing (Phase 3)Study completedNCT03406104
What this trial is testing

RESCUE and REVERSE Long-term Follow-up

Who this might be right for
Leber Hereditary Optic Neuropathy
GenSight Biologics 62
Not applicableStudy completedNCT04961463
What this trial is testing

Evaluation of the Psychoeducation Program Given to Behcet's Patients in the Context of the Roy Adaptation Model

Who this might be right for
PsychoeducationNursing CariesBehcet Syndrome
Ulucanlar Eye Training and Research Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT04936854
What this trial is testing

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

Who this might be right for
Thyroid-Associated Ophthalmopathy
Haukeland University Hospital 60
Not applicableLooking for participantsNCT06359795
What this trial is testing

Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Peking University Third Hospital 50
Not applicableStudy completedNCT04391439
What this trial is testing

Heart Rhythm After Intravenous Methylprednisolone Administration

Who this might be right for
Graves DiseaseGraves OphthalmopathyHeart Rhythm Disorder+3 more
Medical University of Warsaw 40
Large-scale testing (Phase 3)Study completedNCT03298867
What this trial is testing

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

Who this might be right for
Thyroid Eye DiseaseGraves' Orbitopathy
Amgen 83
Next Page